Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil

Clinical trial NCT04993209 · COMPLETED

Trial details

NCT number: NCT04993209
Sponsor: Butantan Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Coronavirus Infections Healthy

Start date: 2021-07-09
Primary completion: 2021-12-10
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.